HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yohei Kawasaki Selected Research

COVID-19

4/2021Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
1/2021A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yohei Kawasaki Research Topics

Disease

15Neoplasms (Cancer)
09/2023 - 10/2017
13Squamous Cell Carcinoma of Head and Neck
04/2024 - 07/2018
11Infections
01/2021 - 08/2015
7Pain (Aches)
11/2023 - 02/2020
7Autism Spectrum Disorder
01/2021 - 01/2016
5Vomiting
12/2023 - 05/2018
5Chronic Hepatitis C
05/2017 - 01/2015
4Cognitive Dysfunction
04/2024 - 01/2016
4Myocardial Infarction
12/2023 - 01/2020
4Nausea
12/2023 - 05/2018
4Head and Neck Neoplasms (Head and Neck Cancer)
07/2022 - 05/2015
4Breast Neoplasms (Breast Cancer)
04/2022 - 11/2016
4Schizophrenia (Dementia Praecox)
01/2022 - 10/2020
4Neutropenia
12/2021 - 11/2016
4Low Back Pain (Lumbago)
06/2021 - 08/2019
3Disease Progression
04/2024 - 02/2021
3Stomach Neoplasms (Stomach Cancer)
12/2023 - 02/2020
3Acute Kidney Injury (Acute Renal Failure)
11/2023 - 01/2020
3Postoperative Pain
03/2023 - 08/2021
3Inflammation (Inflammations)
10/2022 - 01/2021
3Treatment-Resistant Schizophrenia
10/2022 - 10/2020
3Atrial Fibrillation
08/2022 - 01/2020
3Carcinoma (Carcinomatosis)
07/2022 - 01/2021
3Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 01/2017
3Pneumonia (Pneumonitis)
04/2021 - 03/2021
3Hepatitis C
05/2017 - 01/2016
3Human Influenza (Influenza)
02/2017 - 01/2016
2Edema (Dropsy)
10/2023 - 01/2021
2Weight Loss (Weight Reduction)
09/2023 - 01/2022
2Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2023 - 03/2022
2Lung Neoplasms (Lung Cancer)
03/2023 - 01/2020
2Shock
01/2023 - 01/2021
2Hepatocellular Carcinoma (Hepatoma)
12/2022 - 01/2022
2Osteoarthritis
05/2022 - 12/2021
2Melanoma (Melanoma, Malignant)
04/2022 - 01/2022
2Liver Diseases (Liver Disease)
03/2022 - 01/2021
2Allergic Rhinitis
03/2022 - 01/2019
2Critical Illness (Critically Ill)
03/2022 - 01/2019
2Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2022 - 12/2019
2Lung Injury
01/2022 - 01/2020
2Mouth Neoplasms (Oral Cancer)
01/2022 - 08/2019
2Neoplasm Metastasis (Metastasis)
01/2022 - 02/2020
2Colorectal Neoplasms (Colorectal Cancer)
08/2021 - 01/2021
2Hypersensitivity (Allergy)
04/2021 - 10/2019
2COVID-19
04/2021 - 01/2021
2Out-of-Hospital Cardiac Arrest
03/2021 - 01/2019
2Hypesthesia (Numbness)
02/2021 - 01/2021
2Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021 - 01/2016
2Fever (Fevers)
01/2021 - 08/2020

Drug/Important Bio-Agent (IBA)

8Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2019
7InterferonsIBA
05/2020 - 01/2015
6Antipsychotic Agents (Antipsychotics)IBA
04/2022 - 01/2017
5Cisplatin (Platino)FDA LinkGeneric
12/2023 - 05/2018
5AntioxidantsIBA
01/2021 - 04/2017
5Ribavirin (Virazole)FDA LinkGeneric
09/2017 - 01/2016
4AntigensIBA
10/2022 - 01/2020
4Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2018
4TeaIBA
02/2017 - 01/2016
3NivolumabIBA
04/2024 - 06/2020
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
03/2024 - 08/2019
3durvalumabIBA
06/2023 - 01/2022
3Anti-Bacterial Agents (Antibiotics)IBA
09/2022 - 03/2021
3CytokinesIBA
12/2021 - 01/2019
3Tenofovir (Viread)FDA Link
09/2021 - 08/2014
3AntiemeticsIBA
01/2021 - 05/2018
3Oxidants (Oxidizing Agents)IBA
02/2020 - 04/2017
2AnticoagulantsIBA
09/2023 - 07/2019
2Oxytocin (Pitocin)FDA LinkGeneric
10/2022 - 01/2021
2Syntex adjuvant formulationIBA
07/2022 - 11/2019
2afliberceptIBA
01/2022 - 01/2021
2salicylhydroxamic acid (SHAM)IBA
01/2022 - 01/2021
2GemcitabineFDA Link
01/2022 - 08/2017
2Immune Checkpoint InhibitorsIBA
10/2021 - 06/2020
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2021 - 01/2016
2Alanine Transaminase (SGPT)IBA
08/2021 - 01/2016
2Oxygen (Dioxygen)IBA
07/2021 - 04/2021
2Therapeutic UsesIBA
06/2021 - 02/2020
2Antiviral Agents (Antivirals)IBA
04/2021 - 01/2016
2bu-zhong-yi-qi-tangIBA
01/2021 - 11/2019
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 11/2016
2LigandsIBA
01/2021 - 08/2020
2Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2020

Therapy/Procedure

15Drug Therapy (Chemotherapy)
12/2023 - 11/2016
15Therapeutics
11/2023 - 08/2015
4Electrodes (Electrode)
10/2023 - 12/2019
3Anesthesia
12/2023 - 09/2018
3Aftercare (After-Treatment)
06/2023 - 01/2020
3Heavy Ion Radiotherapy
06/2023 - 03/2022
3Chemoradiotherapy
04/2023 - 03/2022
3Radiotherapy
01/2023 - 09/2020
3Esophagectomy
12/2021 - 01/2019
3Kampo Medicine (Kampo)
01/2021 - 11/2019
2Fitness Trackers
11/2023 - 08/2019
2Operative Surgical Procedures
03/2023 - 05/2020
2Wearable Electronic Devices
08/2022 - 01/2020
2Percutaneous Coronary Intervention
01/2022 - 01/2020
2Activities of Daily Living (ADL)
11/2021 - 02/2020
2Induced Hypothermia
03/2021 - 01/2019
2Enteral Nutrition (Feeding, Tube)
03/2021 - 01/2019
2Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 11/2016